| Poki Pagter-newton, BS | |
|
122 Pleasant St, Claremont, NH 03743-2679 | |
| (603) 542-5449 | |
| (603) 542-5455 |
| Full Name | Poki Pagter-newton |
|---|---|
| Gender | Male |
| Speciality | Case Manager/care Coordinator |
| Location | 122 Pleasant St, Claremont, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083963367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
| 171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Poki Pagter-newton, BS 4 Foster Pl, Claremont, NH 03743-5100 Ph: (503) 957-1858 | Poki Pagter-newton, BS 122 Pleasant St, Claremont, NH 03743-2679 Ph: (603) 542-5449 |
News Archive
NanoBio Corporation today announced a licensing agreement with the National Institutes of Health (NIH) that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.
UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
Since the emergence of the coronavirus disease (COVID-19) in China in December 2019, health experts have cautioned that the disease is particularly serious in high-risk populations, including older adults, those with underlying diseases, and those who are immunocompromised. Now, doctors in the United Kingdom warn of a rare and severe inflammatory disease in children with COVID-19.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
Colliers International today announced the results of its 2015 Medical Office Outlook Report, which points to the trend of "retailization" of healthcare as a key driver behind increased demand for healthcare real estate.
› Verified 9 days ago